Ireland· IE-PA-PA2315/254/001
Naloxone Accord
A naloxone product containing naloxone hydrochloride dihydrate, registered in Ireland by Accord Healthcare Ireland Ltd.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Naloxone is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AB15 (naloxone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Naloxone · ATC V03AB15
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Naloxone hydrochloride dihydrate
- Manufacturer
- Accord Healthcare Ireland Ltd.
- Country
- Ireland (IE)
- ATC code
- V03AB15
- ATC class
- Naloxone
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2315/254/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
104 interactions on record for naloxone.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naloxone · interactions on record
104 records
- 2 severe
- 34 moderate
- 4 minor
- 64 info
Most severe, free to view
- DroperidolN01AX01severe
- DroperidolN05AD08severe
- Methylnaltrexone bromideA06AH01moderate
- NaloxegolA06AH03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naloxone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKLOXXADOHikma Specialty USA Inc.
- United KingdomNaloxone 1.26mg/0.1ml nasal spray unit doseA A H Pharmaceuticals Ltd
- GermanyNaloxon AccordAccord Healthcare B.V.
- BelgiumNaloxon B. Braun 0.4 mg/mlB. Braun Melsungen
- CanadaINJECTABLE NALOXONE HYDROCHLORIDEOMEGA LABORATORIES LIMITED
- PolandNaloxone AccordAccord Healthcare Polska Sp. z o.o.
- FinlandNalofarmOrifarm Oy
- SwedenNaloxon actrevo 3,6 mg Nässpray, lösning i endosbehållareActrevo GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Forvel, Naloxon Accord
- Belgium · Naloxon B. Braun
- Bulgaria · Форвел
- Cyprus · Codaxol, Forvel
- Czechia · Forvel, Naloxone Polpharma
- Germany · Naloxon Accord, Naloxon B. Braun
- Denmark · Forvel, Naloxon B. Braun
- Estonia · Forvel, Ventizolve
- Spain · Fomed, Naloxona B. Braun
- Finland · Naloxone Accord, Nexodal
- France · Naloxone Accord, Naloxone Adapt Pharma
- United Kingdom (Northern Ireland) · Naloxone Accord-Uk, Naloxone B. Braun Melsungen
- Greece · Forvel, Νaloxon B.Braun
- Croatia · Forvel
- Hungary · Nexodal
- Iceland · Naloxon B. Braun, Nyxoid
- Italy · Naloxone Accord, Naloxone Adapt
- Liechtenstein · Nyxoid
- Lithuania · Forvel
- Luxembourg · Naloxon B. Braun
- Latvia · Forvel
- Malta · Forvel
- Netherlands · Naloxon Hci B. Braun, Naloxon Hcl Accord
- Norway · Naloxon B. Braun, Naloxon Hameln
- Poland · Naloxonum Hydrochloricum Wzf
- Portugal · Forvel, Naloxona Accord
- Romania · Forvel
- Sweden · Naloxon Actrevo, Naloxon Hameln
- Slovenia · Nexodal
- Slovakia · Naloxone Polpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6a57ce32-39ea-4f40-b3b7-bbdbbe3645d4 GET /v1/drugs/6a57ce32-39ea-4f40-b3b7-bbdbbe3645d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"routes": [
"Intramuscular use",
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V03AB15"
],
"strength": null,
"pa_number": "PA2315/254/001",
"substances": [
"Naloxone hydrochloride dihydrate"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "30/06/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about naloxone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.